Antitumor antibiotic BMY-42448
US5082933A · kind A · utility
2Cited by
2References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 10, 1990 |
| Grant date | Jan 21, 1992 |
| Priority date | — |
| Expiry date | Jan 10, 2010 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H17/08
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A new antibiotic designated BMY-42448 is produced by fermentation of Micromonospora narashinoensis strain C39217-R109-7 (ATCC-53791). BMY-42448 exhibits both in vitro and in vivo antitumor activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.